Cybin Taps First-of-Its-Kind Device to Study Psychedelic Effects of Ketamine

Cybin Taps First-of-Its-Kind Device to Study Psychedelic Effects of Ketamine

A new device may help Cybin better understand the psychedelic impact of the drug ketamine on the human brain.
Research Looks at Psychedelics for Autism Treatment

Research to Look at Psychedelics for Autism Treatment

New research from Nova Mentis will explore the potential benefits of psychedelics in treating autism spectrum disorders.
FDA Approves First-Ever MDMA Study for Therapist Volunteers to Better Treat PTSD Patients

FDA Approves First-Ever MDMA Study for Therapist Volunteers to Better Treat PTSD Patients

The FDA has approved a novel study allowing therapists who treat PTSD to take MDMA to better understand the treatment benefits.
UNLV Researchers Discover a Brainwave Signature That Responds to Psychedelic Medicine

Algernon to Become the First Company in the World to Study DMT for Stroke Patients

Algernon Pharmaceuticals has received FDA approval to study DMT for use in stroke patients to help rebuild synaptic connections.
FDA Greenlights Ketamine for Parkinson's Disease Treatment

FDA Green-Lights Ketamine Study for Side Effects of Parkinson’s Disease Treatment

Research into ketamine as a potential treatment for Parkinson's patients suffering from drug side effects is getting FDA approval.
Can Psychedelics Cure Color Blindness

Could Psychedelics Cure Color Blindness? New Data Sees a Bright Future

Could psychedelics help people suffering from color blindness? New research sees great potential with lsd and psilocybin.
The World Boxing Council is the First Global Sports Governing Body to Research Psychedelic Treatment for Brain Injuries

The World Boxing Council Is the First Global Sports Governing Body to Research Psychedelic Treatment for Brain Injuries

Treating traumatic brain injury with psychedelics will get a closer study in a partnership between the World Boxing Council and Wesana Health.
Oregon’s Democratic Party Endorses Legalization of Psilocybin

Wake Receives First-Ever Approval for Psilocybin Microdose Study for Anxiety and Depression

,
In the first approval of its kind, Wake Network will study the effects of microdosing psilocybin on anxiety and depression.
How to Become a Psychedelic Facilitator

MDMA Study Finds More Than 60% Success Rate in PTSD Patients

New hope for PTSD sufferers as a study found a more than 60% success rate after taking MDMA in a clinical setting.
NIMH Addresses Critical Need for Fast-Acting Interventions for Severe Suicide Risk

NIMH Supports 8 Interventions for Severe Suicide Risk Including Ketamine, Esketamine

New treatment interventions approved by NIMH for use with high-suicide risks include two novel ketamine therapies.